Skip to main content
Signal8

Regencell Bioscience Holdings Ltd (RGC)

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

NASDAQ:RGCHealthcare
-11.86%$6.76
AH Close$6.71-0.77%vs close
Mkt Cap$3.35B
Float17.8M
O/S495.88M
Inst Own0.3%
SI2.5%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$3.35B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.28%

based on 495.88M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
CountryHKHK
IPO DateJul 16, 2021
Shares Outstanding495.88M
Float17.80M
Company Overview

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM).

Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration.

The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

Leadership

Alex Yemenidjian

Guess?, Inc.

Amy E. Miles

Norfolk Southern Corporation

Charles E. Brymer

David H. Keyte

Employees

12

Country

HK

Sector

Healthcare

Website

regencellbioscience.com

Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
No price targets available
Ratings Distribution
BUY
0
HOLD
4
SELL
0
TOTAL4
Insider Trades
InsiderTypeShares
LO WILLIAM WING YAN DR profile photoLO WILLIAM WING YAN DRWithholding/Transfer70.6K
HUI EVANA YEE WAH profile photoHUI EVANA YEE WAHWithholding/Transfer19.0K
Shareholders
0.3%
Institutional
(35)
0.2%
Insiderⓘ
(2)
86.0%
5%+ Owners
(1)
13.5%
Unattributed (incl. retail)ⓘ
Institutional0.3%
Insider0.2%
5%+ Beneficial86.0%
Unattributed (incl. retail)13.5%
Top Shareholders
NameShares%
Regencell (BVI) Limited logo
Regencell (BVI) Limited
· may incl. warrants· filed Jul 2025
426.4M86.0%
LO MARGARET HOOR HAN profile photo
LO MARGARET HOOR HAN
Director
604.0K0.1%
AU YAT-PUI profile photo
AU YAT-PUI
Chief Business Officer
581.5K0.1%
GEODE CAPITAL MANAGEMENT, LLC logo
GEODE CAPITAL MANAGEMENT, LLC
422.0K0.1%
Alyeska Investment Group, L.P. logo
Alyeska Investment Group, L.P.
416.3K0.1%
Legal & General Group Plc logo
Legal & General Group Plc
128.0K0.0%
JANE STREET GROUP, LLC logo
JANE STREET GROUP, LLC
98.3K0.0%
XTX Topco Ltd logo
XTX Topco Ltd
60.1K0.0%
Amundi logo
Amundi
47.2K0.0%
UBS Group AG logo
UBS Group AG
43.2K0.0%
Sources: 13F, Form 4, 13D/13GO/S: 495.9M · as of 30 Jun 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$4.51$69.00
$6.76(3rd percentile)
Volume
Average Daily Volume400.01K
450.56K today vs 400.01K avg(+13%)

30d Avg

400.01K

60d Avg

296.65K

90d Avg

251.79K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...